Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology
— Technology currently being evaluated for the treatment of ovarian cancer in Phase 1 clinical trial — SAN JOSE, Calif., July 11, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. , a...
Source: marketscreener.com